Versant Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Versant Capital Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-118	Closed	-$5K	–	1682
2020 Q1	$5K	Buy	+118	New	+$5.49K	﹤0.01%	806

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Versant Capital Management's RARX Position: Q2 2020 in Review

Versant Capital Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 118 shares — an estimated $5K sold.

Versant Capital Management first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $5K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Versant Capital Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Versant Capital Management sold 118 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $5K.
Versant Capital Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Versant Capital Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $5K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Versant Capital Management's 13F filing for Q2 2020, filed 16 Jul 2020.